TREANDA - 63459-390-08 - (bendamustine hydrochloride)

Alphabetical Index


Drug Information of TREANDA

Product NDC: 63459-390
Proprietary Name: TREANDA
Non Proprietary Name: bendamustine hydrochloride
Active Ingredient(s): 25    mg/5mL & nbsp;   bendamustine hydrochloride
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of TREANDA

Product NDC: 63459-390
Labeler Name: Cephalon, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022249
Marketing Category: NDA
Start Marketing Date: 20080320

Package Information of TREANDA

Package NDC: 63459-390-08
Package Description: 5 mL in 1 VIAL, SINGLE-USE (63459-390-08)

NDC Information of TREANDA

NDC Code 63459-390-08
Proprietary Name TREANDA
Package Description 5 mL in 1 VIAL, SINGLE-USE (63459-390-08)
Product NDC 63459-390
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name bendamustine hydrochloride
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20080320
Marketing Category Name NDA
Labeler Name Cephalon, Inc.
Substance Name BENDAMUSTINE HYDROCHLORIDE
Strength Number 25
Strength Unit mg/5mL
Pharmaceutical Classes Alkylating Activity [MoA],Alkylating Drug [EPC]

Complete Information of TREANDA


General Information